mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-18 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-16 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-13 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-13 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-13 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-12 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-12 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-12 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-11 |